GlassScriptPhysician profile
Jesus Vazquez
NPI 1891841144
$21,688.52
in general payments reported to CMS, 2019-2025
39 companies · $2,348 in 2025
The $2,348 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,819 · 2020: $1,208 · 2021: $2,195 · 2022: $2,994 · 2023: $4,031 · 2024: $4,094 · 2025: $2,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,720 · Travel and Lodging: $1,726 · Consulting Fee: $1,025 · Education: $3.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,719.76 |
| Travel and Lodging | $1,725.65 |
| Consulting Fee | $1,025.00 |
| Education | $3.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,530.13 | 2019-2025 | Aveir, Gallant, Jot Dx |
| Boston Scientific Corporation | $5,013.25 | 2019-2025 | Emblem Mri S-Icd, Accolade Sr, Farapulse |
| Medtronic, INC. | $1,807.38 | 2021-2025 | Micra, Reveal Linq, Aurora Ev-Icd Mri Surescan |
| Atricure, INC. | $1,775.95 | 2019-2024 | |
| Pfizer INC. | $1,185.17 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $934.68 | 2019-2025 | |
| Medtronic Vascular, INC. | $668.04 | 2019-2020 | |
| Amgen INC. | $631.75 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $497.02 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $495.93 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $407.65 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $363.10 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.39 | 2021-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $208.16 | 2021-2025 | Amvuttra |
| Cardiva Medical, INC. | $185.18 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Vazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.